Clinical Trial Update: Antiseizure Medication in Seizure Networks at Early Acute Brain Injury [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an antiseizure medication for seizure networks in early acute brain injury was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury
• Brain Ischemia
• Coma
• Hypoxic-ischemic Brain Injury
• Intracranial Hemorrhage
• Persistent Vegetative State
• Stroke
• Traumatic Brain Injury

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Brain Injuries, Acute, Brain Injuries, Traumatic | Phase 4 | Status: TERMINATED | Results posted: 2025-11-14